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Introduction
Pemphigus is an autoimmune bullous disorder characterized by autoantibodies to keratinocyte cell surface components. The two major types of pemphigus, pemphigus vulgaris (PV) and pemphigus foliaceus with malignancy such as lung cancer [2, 3] , ovarian [4] and gall bladder carcinoma [5] , endometrial [6] and pancreatic adenocarcinoma [7] . Immunoblotting of patient's serum IgG and IgA using normal human One year after the initial presentation the patient was diagnosed with poorly differentiated squamous cell carcinoma of the lung with metastases to the mediastinum, abdominal lymph nodes and the liver. He received three cycles of gemcitabine and carboplatin, while being maintained on 200 mg/day of dapsone and 20 mg/day of prednisone with absence of skin lesions.
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Discussion and Conclusion
We describe a case of atypical pemphigus, with overlapping clinical features of IgA pemphigus and PF. This case fits under the definition of IgG/IgA pemphigus as it demonstrated epidermal acantholysis and cell surface deposition of both IgG and IgA. We further detected IgG antibodies reactive with Dsg1 and Dsc3, and IgA antibodies reactive with Dsg1. The definition of IgG/IgA pemphigus is, however, somewhat general, and controversy exists as to whether it represents a separate disease entity [1] . The coexistence of both IgG and IgA autoantibodies to keratinocyte cell surface antigens does not appear to be unique to IgG/IgA pemphigus, as a study by Mentink et al. [8] retrospectively demonstrated the existence of IgA autoantibodies to Dsg1 and Dsg3 in patients previously diagnosed with PF, PV and PNP who also had IgG autoantibodies. Interestingly, the authors also observed that in the majority of cases IgG and IgA antibodies reacted with the same autoantigen [8] . The overlapping clinical features described in cases of IgG/IgA pemphigus suggest the existence of a spectrum of pemphigus diseases, from purely IgG-mediated to purely IgA-mediated as either extreme of such a spectrum.
Most of the cases of IgG/IgA pemphigus, including the present case, demonstrated IgG and IgA antibody reactivity with the same autoantigen. It is not clear whether both Ig isotypes recognize the same epitope on the desmogleins, and whether they are produced by the same plasma cell clone following an isotype switch. Such clonogenic rearrangement of the Ig heavy chain has been described for multiple myeloma, and may result in the emergence of an IgA clone from an IgG clone, and vice versa [9] . Such investigations have not, to our knowledge, been undertaken in the field of immunobullous diseases. Characterizing the mechanism which leads to the emergence of several auto-Ig isotypes in pemphigus may help better classify and diagnose this class of diseases.
Approximately one-third of IgG/IgA pemphigus cases described in the literature, as well as the present case, have been associated with malignancy [2] [3] [4] [5] [6] [7] . This is in contrast to "pure" IgA pemphigus, in which paraproteinemias have been reported in up to 20% of cases, but lymphoproliferative and solid tumor malignancies are rare [10] . The association of IgG/IgA pemphigus with malignancy suggests that a comprehensive history should be obtained in all cases and cancer screening should be considered where appropriate, especially in cases with recalcitrant and progressive skin disease. In the above case, it is possible that the lung carcinoma was present at the initial presentation, but was only diagnosed at an advanced stage one year later.
The significance of the antibodies to two autoantigens (Dsg1 and Dsc3) and the pathogenic role of anti-Dsc3 antibodies are not well understood. Recent reports established that Dsc3 is a tumor suppressor and a marker of squamous carcinoma of the lungs [11, 12] . Reduced expression of Dsc3 correlated with poor clinical outcome in patients with lung cancer [13] . The presence of anti-Dsc3 antibodies in the above case of IgG/IgA pemphigus with poorly differentiated squamous cell carcinoma of the lungs raises questions about a possible pathogenic role of anti-Dsc3 antibodies. Do autoantibodies to Dsc3 contribute to carcinogenesis or metastasis? Are anti-Dsc3 antibodies a marker of internal malignancy? Additional studies are required to better characterize atypical pemphigus cases with IgG and IgA autoantibodies and their associations with malignancy. 
